f | { | f | { |
n | | n | "author": "", |
| | | "author_email": "", |
| "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", | | "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", |
| "groups": [ | | "groups": [ |
| { | | { |
| "description": "Group for publications", | | "description": "Group for publications", |
| "display_name": "Publication", | | "display_name": "Publication", |
| "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", | | "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", |
| "image_display_url": | | "image_display_url": |
| mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", | | mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", |
| "name": "publication", | | "name": "publication", |
| "title": "Publication" | | "title": "Publication" |
| } | | } |
| ], | | ], |
| "id": "eae571a9-f29c-4235-afd8-e4979cf5a69a", | | "id": "eae571a9-f29c-4235-afd8-e4979cf5a69a", |
| "isopen": false, | | "isopen": false, |
n | "license_title": null, | n | "license_id": "notspecified", |
| | | "license_title": "License not specified", |
| "maintainer": null, | | "maintainer": null, |
| "maintainer_email": null, | | "maintainer_email": null, |
| "metadata_created": "2021-09-16T08:11:54.304973", | | "metadata_created": "2021-09-16T08:11:54.304973", |
n | "metadata_modified": "2022-04-05T00:52:33.288343", | n | "metadata_modified": "2022-04-27T07:15:22.040709", |
| "name": "malawi-integrated-hiv-program-report-2013-q2", | | "name": "malawi-integrated-hiv-program-report-2013-q2", |
n | | n | "notes": "This is the 8th quarterly HIV Program report after |
| | | implementation of the 2011 Integrated Clinical\r\nHIV Guidelines in |
| | | July 2011. A summary of the key achievements between April and June |
| | | 2013 is\r\nprovided below:\r\n\r\n* Scale-up of integrated HIV |
| | | services had reached the following number of sites:\r\n\r\n * |
| | | __825__ static (607 within and 218 outside of health facilities) and |
| | | 534 outreach HTC sites\r\n\r\n * __671__ (static) ART sites\r\n |
| | | \r\n * __588__ PMTCT sites (Option B+)\r\n \r\n * __623__ |
| | | Pre-ART sites\r\n \r\n * __603__ sites with HIV-exposed child |
| | | follow-up\r\n\r\n* 462,334 persons were tested and counselled for HIV |
| | | and 37,852 (8%) were HIV positive;\r\n156,875 (34%) people tested for |
| | | the first time.\r\n\r\n* 16,763 (98%) of 17,142 blood units collected |
| | | were screened for HIV, hepatitis B and syphilis.\r\n\r\n* __113,061 |
| | | (77%)__ of __147,586__ women at ANC had their HIV status ascertained; |
| | | __9,282 (8%)__ of\r\nthese were HIV positive. __108,861 (92%)__ of |
| | | __118,402__ women at maternity had their HIV status\r\nascertained; |
| | | __8,285 (8%)__ of these were HIV positive.\r\n\r\n* __26,802__ |
| | | patients started ART during this quarter; this is similar to the |
| | | previous quarter\r\n(26,881).\r\n\r\n* __443,221__ patients were alive |
| | | and on ART by end of June 2013. This is equivalent to 74%\r\ncoverage |
| | | of the estimated __602,000__ population in need of ART (all ages; 2013 |
| | | Spectrum\r\nestimates based on current definition of eligibility for |
| | | ART in Malawi).\r\n\r\n* __105,326 (26%)__ of __408,013__ on first |
| | | line adult regimens were on ART regimen 5A (tenofovir /\r\nlamivudine |
| | | / efavirenz).\r\n\r\n* __80%__ of adults and __82%__ of children were |
| | | retained alive on ART at 12 months after ART\r\ninitiation.\r\n\r\nA |
| | | total of __11,452__ HIV positive pregnant women were on ART: __4,343 |
| | | (38%)__ of these were\r\nalready on ART when getting pregnant and |
| | | 7,109 (62%) started ART during\r\npregnancy/delivery. This is |
| | | equivalent to 73% ART coverage among the estimated __15,750__\r\nHIV |
| | | infected pregnant women in Malawi this quarter. __6,910 (97%)__ of |
| | | pregnant women\r\nstarted ART due to Option B+ (in WHO clinical stage |
| | | 1 or 2) and 199 (3%) due to a low CD4\r\ncount and/or WHO clinical |
| | | stage 3 or 4.\r\n\r\nAn additional __2,164__ breastfeeding women |
| | | started ART due to Option B+ (in WHO clinical\r\nstage 1 or |
| | | 2).\r\n\r\n__5,941 (77%)__ of __7,709__ women started under Option B+ |
| | | were retained at 6 months after ART\r\ninitiation; __5,778 (76%)__ of |
| | | __7569__ were retained at 12 months after ART initiation.\r\n\r\n* |
| | | __7,520 (7%)__ of infants discharged alive from maternity were known |
| | | to be HIV exposed, __7,005\r\n(93%)__ of these received ARV |
| | | prophylaxis (nevirapine). __5,026 (67%)__ were enrolled in |
| | | exposed\r\nchild follow-up before age 2 months.\r\n\r\n* A total of |
| | | __10,277__ HIV exposed children and __9,886__ pre-ART patients were |
| | | enrolled for followup\r\nin HIV Care Clinics (HCC) during this |
| | | quarter.\r\n\r\n* __112__ medical staff were newly trained and |
| | | certified in PMTCT/ART this quarter. This brings\r\nthe total number |
| | | trained in the 2011 guidelines to __5,823__.\r\n\r\n* About __300__ |
| | | staff (mainly HSAs) at 52 facilities received mentoring for collection |
| | | of dried\r\nblood samples for Early Infant Diagnosis and documentation |
| | | of results.\r\n\r\n* __2,533__ HTC providers were re-trained using the |
| | | HTC Skills Intensive Training curriculum.\r\n\r\n* A total of __61__ |
| | | staff at __46__ sites in 4 districts received clinical mentoring |
| | | during a total of __90__\r\nmentoring visits (mentoring program |
| | | reports remained incomplete for this quarter).", |
| "num_resources": 1, | | "num_resources": 1, |
| "num_tags": 1, | | "num_tags": 1, |
| "organization": { | | "organization": { |
| "approval_status": "approved", | | "approval_status": "approved", |
| "created": "2021-10-14T11:02:35.234558", | | "created": "2021-10-14T11:02:35.234558", |
n | "description": "Department of HIV & AIDS and Viral Hepatitis", | n | "description": "The Department of HIV & AIDS (DHA) was established |
| | | in 2001, initially as a unit in the Department of Clinical Services, |
| | | to coordinate the biomedical HIV Program in Malawi. The department now |
| | | carries responsibility for various HIV related programs including: |
| | | sexually transmitted infections (STIs), prevention of mother to child |
| | | transmission of HIV (PMTCT), and national voluntary male medical |
| | | circumcision program (VMMC). All these HIV program sub-sections are |
| | | linked to one robust monitoring and evaluation sub-section in the HIV |
| | | and AIDS Department which technically operates under the Central |
| | | Monitoring and Evaluation Department (CMED) of the Ministry of |
| | | Health.", |
| "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
n | "image_url": "", | n | "image_url": |
| | | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", |
| "is_organization": true, | | "is_organization": true, |
| "name": "dha", | | "name": "dha", |
| "state": "active", | | "state": "active", |
t | "title": "Department of HIV & AIDS", | t | "title": "Department of HIV & AIDS and Viral Hepatitis", |
| "type": "organization" | | "type": "organization" |
| }, | | }, |
| "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "private": false, | | "private": false, |
| "program_area": "Care and Treatment", | | "program_area": "Care and Treatment", |
| "relationships_as_object": [], | | "relationships_as_object": [], |
| "relationships_as_subject": [], | | "relationships_as_subject": [], |
| "resources": [ | | "resources": [ |
| { | | { |
| "cache_last_updated": null, | | "cache_last_updated": null, |
| "cache_url": null, | | "cache_url": null, |
| "created": "2022-03-23T19:55:50.009777", | | "created": "2022-03-23T19:55:50.009777", |
| "description": "", | | "description": "", |
| "format": "PDF", | | "format": "PDF", |
| "hash": "", | | "hash": "", |
| "id": "9b399877-1a6e-44e6-897a-884e18857030", | | "id": "9b399877-1a6e-44e6-897a-884e18857030", |
| "last_modified": "2022-04-05T00:52:33.279840", | | "last_modified": "2022-04-05T00:52:33.279840", |
| "lfs_prefix": | | "lfs_prefix": |
| "dha/malawi-integrated-hiv-program-report-2013-q2", | | "dha/malawi-integrated-hiv-program-report-2013-q2", |
| "metadata_modified": "2022-04-05T00:52:33.292631", | | "metadata_modified": "2022-04-05T00:52:33.292631", |
| "mimetype": "application/pdf", | | "mimetype": "application/pdf", |
| "mimetype_inner": null, | | "mimetype_inner": null, |
| "name": "malawi-integrated-hiv-program-report-2013-q2", | | "name": "malawi-integrated-hiv-program-report-2013-q2", |
| "package_id": "eae571a9-f29c-4235-afd8-e4979cf5a69a", | | "package_id": "eae571a9-f29c-4235-afd8-e4979cf5a69a", |
| "position": 0, | | "position": 0, |
| "resource_type": null, | | "resource_type": null, |
| "sha256": | | "sha256": |
| "9ce52c9ea5c50ddc42cb335ddc1b2afcd7ef0c0558762e634dc46da0f296e750", | | "9ce52c9ea5c50ddc42cb335ddc1b2afcd7ef0c0558762e634dc46da0f296e750", |
| "size": 1921572, | | "size": 1921572, |
| "state": "active", | | "state": "active", |
| "url": | | "url": |
| 4e18857030/download/malawi-integrated-hiv-program-report-2013-q2.pdf", | | 4e18857030/download/malawi-integrated-hiv-program-report-2013-q2.pdf", |
| "url_type": "upload" | | "url_type": "upload" |
| } | | } |
| ], | | ], |
| "state": "active", | | "state": "active", |
| "tags": [ | | "tags": [ |
| { | | { |
| "display_name": "Report", | | "display_name": "Report", |
| "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", | | "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", |
| "name": "Report", | | "name": "Report", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| } | | } |
| ], | | ], |
| "title": "Malawi Integrated HIV Program Report 2013 Q2", | | "title": "Malawi Integrated HIV Program Report 2013 Q2", |
| "type": "dataset", | | "type": "dataset", |
| "url": null, | | "url": null, |
| "version": null, | | "version": null, |
| "year": "2013" | | "year": "2013" |
| } | | } |